Acasti Pharma (NQ: ACST )
2.450
+0.050
(+2.08%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Acasti Pharma
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
Acasti Pharma Reports Third Quarter 2023 Operational Results
February 14, 2023
From Acasti Pharma, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
From Acasti Pharma, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
Acasti Pharma Reports Second Quarter 2023 Operational Results
November 14, 2022
From Acasti Pharma, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
Acasti Pharma to Present at Q4 Investor Summit
November 09, 2022
From Acasti Pharma, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
![](https://ml.globenewswire.com/media/b261801f-6542-4b63-9fb9-715411731ac7/small/acasti-pharma-jpg.jpg)
Acasti Announces Court Dismissal of Stockholder Litigation
September 30, 2022
From Acasti Pharma, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/b261801f-6542-4b63-9fb9-715411731ac7/small/acasti-pharma-jpg.jpg)
Acasti Announces Voting Results from 2022 Annual and Special Meeting of Shareholders
September 29, 2022
From Acasti Pharma, Inc.
Via GlobeNewswire
Acasti Pharma Inc. Discusses Clinical Progress of Lead Assets and 2022 Catalysts with The Stock Day Podcast
September 21, 2022
Via Newsfile
Exposures
Product Safety
![](https://ml.globenewswire.com/media/b261801f-6542-4b63-9fb9-715411731ac7/small/acasti-pharma-jpg.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/16344.jpg?v=0)
From MicroCap Rodeo
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/32330.jpg?v=1)
![](https://mms.businesswire.com/media/20210512006042/en/1064495/4/2021-03-29-ksf-logo-ma.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.